Ivan Borrello

Ivan Borrello is an internationally recognized expert on immunotherapy for multiple myeloma. His group was the first to describe the use of marrow infiltrating lymphocytes (MILs) as a source of highly tumor-specific T cells for adoptive T cell therapy. This work has led to several clinical trials in which his group showed the ability of activated MILs to impart measurable tumor-specific immunity. His group is also exploring various approaches to enhance the use of MILs in a variety of different settings and in diseases other than myeloma. Dr. Borrello is an Associate Professor at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in the divisions of Tumor Immunology and Hematologic Malignancies. He received his MD degree from the Medical College of Virginia. Completed his Residency in Internal Medicine at the University of Chicago and his Fellowship in Oncology at Johns Hopkins where he then has continued as a faculty member. He also serves as the medical director of the Cell Therapy Lab.